Your browser doesn't support javascript.
loading
Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype.
Maus, Mate; López-Polo, Vanessa; Mateo, Lidia; Lafarga, Miguel; Aguilera, Mònica; De Lama, Eugenia; Meyer, Kathleen; Sola, Anna; Lopez-Martinez, Cecilia; López-Alonso, Ines; Guasch-Piqueras, Marc; Hernandez-Gonzalez, Fernanda; Chaib, Selim; Rovira, Miguel; Sanchez, Mayka; Faner, Rosa; Agusti, Alvar; Diéguez-Hurtado, Rodrigo; Ortega, Sagrario; Manonelles, Anna; Engelhardt, Stefan; Monteiro, Freddy; Stephan-Otto Attolini, Camille; Prats, Neus; Albaiceta, Guillermo; Cruzado, Josep M; Serrano, Manuel.
Afiliación
  • Maus M; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. matemaus@vhio.net.
  • López-Polo V; Vall d'Hebron Institute of Oncology, Barcelona, Spain. matemaus@vhio.net.
  • Mateo L; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Lafarga M; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Aguilera M; Departamento de Anatomía y Biología Celular, Universidad de Cantabria-IDIVAL, Santander, Spain.
  • De Lama E; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Meyer K; Radiology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Sola A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Lopez-Martinez C; Altos Labs, Cambridge Institute of Science, Cambridge, UK.
  • López-Alonso I; Nephrology and Renal Transplantation Research Group. Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
  • Guasch-Piqueras M; Departamento de Biología Funcional, Instituto Universitario de Oncología del principado de Asturias, Universidad de Oviedo, Oviedo, Spain.
  • Hernandez-Gonzalez F; Unidad de Cuidados Intensivos Cardiológicos. Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Chaib S; CIBER-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
  • Rovira M; Departamento de Morfología y Biología Celular, Universidad de Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Sanchez M; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Faner R; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Agusti A; Department of Pulmonary Medicine, Respiratory Institute, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Diéguez-Hurtado R; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Ortega S; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Manonelles A; Iron Metabolism: Regulation and Diseases Group, Department of Basic Sciences, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, Spain.
  • Engelhardt S; Biomedicine Department, University of Barcelona, IDIBAPS, CIBERES, Barcelona, Spain.
  • Monteiro F; Universitat de Barcelona, Institut Respiratori, Hospital Clinic, IDIBAPS, CIBERES, Barcelona, Spain.
  • Stephan-Otto Attolini C; Deparment of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
  • Prats N; Transgenics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Albaiceta G; Nephrology and Renal Transplantation Research Group. Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
  • Cruzado JM; Nephrology Department, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain.
  • Serrano M; Department of Clinical Sciences, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
Nat Metab ; 5(12): 2111-2130, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38097808
ABSTRACT
Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases. Senescent cells are a main driver of fibrotic diseases through their secretome, known as senescence-associated secretory phenotype (SASP). Here, we report that cellular senescence, and multiple types of fibrotic diseases in mice and humans are characterized by the accumulation of iron. We show that vascular and hemolytic injuries are efficient in triggering iron accumulation, which in turn can cause senescence and promote fibrosis. Notably, we find that senescent cells persistently accumulate iron, even when the surge of extracellular iron has subdued. Indeed, under normal conditions of extracellular iron, cells exposed to different types of senescence-inducing insults accumulate abundant ferritin-bound iron, mostly within lysosomes, and present high levels of labile iron, which fuels the generation of reactive oxygen species and the SASP. Finally, we demonstrate that detection of iron by magnetic resonance imaging might allow non-invasive assessment of fibrotic burden in the kidneys of mice and in patients with renal fibrosis. Our findings suggest that iron accumulation plays a central role in senescence and fibrosis, even when the initiating events may be independent of iron, and identify iron metabolism as a potential therapeutic target for senescence-associated diseases.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Senescencia Celular / Fenotipo Secretor Asociado a la Senescencia Límite: Humans Idioma: En Revista: Nat Metab Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Senescencia Celular / Fenotipo Secretor Asociado a la Senescencia Límite: Humans Idioma: En Revista: Nat Metab Año: 2023 Tipo del documento: Article País de afiliación: España